BPA Call HT001424A0002-HT009026FG0210049
Award Date 2/4/26
Potential Completion Date 9/30/26
Potential Value $22K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Sterling, VA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded Sofie CO., doing business as IBA Molecular, a BPA call order valued at $249,801.68 on January 15, 2026, for the supply of radioactive pharmaceuticals required for positron emission tomography (PET) imaging. The contract, which carries a firm fixed-price structure with no set-aside designation, is scheduled for completion by January 14, 2027, and will be performed in Bethesda, Maryland. This call order is issued under a larger blanket purchase agreement vehicle...
- Sofie CO., doing business as IBA Molecular, received a Blanket Purchase Agreement (BPA) call award from the Defense Health Agency valued at $36,087.20 with a firm fixed-price structure and no set-aside designation. The contract, awarded on November 4, 2025, supports the delivery of pharmaceuticals needed for patient care, with performance to be completed by September 30, 2026, at the contractor's location in Sterling, Virginia. As a specialized supplier of molecular diagnostics and therapeutic...
- The Defense Health Agency awarded Sofie CO. (doing business as IBA Molecular) a $25,261.04 firm fixed-price call under an existing blanket purchase agreement on December 2, 2025, for radiopharmaceutical delivery supporting prostate cancer imaging in patients with metastatic lesions following definitive treatment. The contract, which carries no set-aside designation, will be performed in Sterling, Virginia, with an ultimate completion date of September 30, 2026. This award represents a task order...
- The Defense Health Agency awarded a $14,434.88 firm fixed-price contract call to Sofie CO. (doing business as IBA Molecular) on June 24, 2025, for the provision of radiopharmaceuticals needed to treat prostate cancer patients with metastatic lesions following definitive treatment. The contract will be performed in Sterling, Virginia, and is scheduled for completion by September 30, 2025. This task order was issued under an existing Blanket Purchase Agreement and carries no set-aside designation,...
- The Department of Veterans Affairs Veterans Integrated Service Network 4 awarded a $1.88M firm fixed-price purchase order to Sofie CO. (doing business as IBA Molecular) on June 30, 2022, for F-18 radiopharmacy services through June 30, 2024. Sofie CO., a subsidiary of Sofie Biosciences, Inc. headquartered in Sterling, Virginia, is a specialized manufacturer and supplier of molecular diagnostics and therapeutic radiopharmaceuticals. The contract carries no set-aside designation and reflects...
- The Defense Health Agency awarded a $32,478 fixed-price blanket purchase agreement call contract to Sofie CO, doing business as Sofie, to provide radiopharmaceuticals needed for patient care. Sofie Biosciences, Inc. is the parent company of Sofie CO. The place of performance will be Sterling, Virginia and the period of performance is September 18-30, 2023. This small business set-aside contract was awarded under an existing indefinite-delivery/indefinite-quantity radiopharmaceuticals contract...
- This delivery order, awarded September 1, 2024, represents Option Year 2 of an existing contract vehicle with Sofie CO. (doing business as IBA Molecular), a Sterling, Virginia-based supplier of molecular diagnostics and therapeutic radiopharmaceuticals. The $194,870.88 firm fixed-price delivery order is funded by the Department of Veterans Affairs through Veterans Integrated Service Network 15 and is scheduled for completion by August 31, 2027. This award carries no set-aside designation and...
- The U.S. Department of Veterans Affairs, through Veterans Integrated Service Network 4, awarded a $1.39 million firm fixed-price purchase order to Sofie CO. (doing business as IBA Molecular) on May 1, 2024, for the supply of FDG (fluorodeoxyglucose) and NEURACEQ (florbetaben F-18) radiopharmaceuticals. These PET (positron emission tomography) imaging agents are critical diagnostic tools used for oncology imaging and Alzheimer's disease detection, respectively, supporting the VA's medical imaging...
- Sofie CO., operating as IBA Molecular, received a delivery order award valued at $339.6K on January 22, 2026, for radioactive isotopes and positron emission tomography (PET) tracers supporting the Michael E. DeBakey VA Medical Center in Sterling, Virginia. This delivery order, with an ultimate completion date of February 28, 2027, is structured as a firm fixed-price contract with no set-aside designation. The award is issued under a larger indefinite delivery vehicle with VA Veterans...
- This is a federal contract awarded by the Defense Health Agency (DHA) to Sofie CO., doing business as Sofie, for the delivery of radiopharmaceuticals. The contract, valued at $36,087.20, is a Blanket Purchase Agreement (BPA) Call with a firm fixed price. The contract has a completion date of September 30, 2024. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, including radiopharmaceuticals, to various...